Monitor System for the Safety of Dabigatran Treatment (MISSION-AF)
A Monitor System for the Safety of Dabigatran Anticoagulation Treatment in Nonvalvular Atrial Fibrillation
Sponsor: Ministry of Science and Technology of the People´s Republic of China
A observational or N/A phase clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Ministry of Science and Technology of the People´s Republic of China and has accumulated 12 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Oct 2019 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2018 — Oct 2019 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
May 2017 — Aug 2017 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Science and Technology of the People´s Republic of China
- Second Affiliated Hospital of Nanchang University
For direct contact, visit the study record on ClinicalTrials.gov .